Page 63 - Read Online
P. 63
Page 380 Sale et al. Cancer Drug Resist 2019;2:365-80 I http://dx.doi.org/10.20517/cdr.2019.14
48. Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr
2015;9:317-24.
49. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting
inactivation of premature senescence. Cancer Cell 2008;14:79-89.
50. Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC. Zeb1 links epithelial-mesenchymal transition and cellular senescence.
Development 2008;135:579-88.
51. Ohashi S, Natsuizaka M, Wong GS, Michaylira CZ, Grugan KD, et al. Epidermal growth factor receptor and mutant p53 expand
an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res
2010;70:4174-84.
52. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene
2010;29:4741-51.